PSCore platform delivered over 500 characterized iPSC lines during first year of collaboration . SAN DIEGO, CA, 11 March 2026 ...
An innovative stem cell therapy approved for severe heart failure has been cleared for use in Japan. Here is why it matters ...
GERMANTOWN, MD / ACCESS Newswire / March 16, 2026 / uBriGene Biosciences (uBriGene), a global CDMO leader, is excited to announce that its strategic partner, Grit Biotechnologies, has received FDA cle ...
Morning Overview on MSN
Japan approves world-first iPSC therapy for Parkinson’s disease
Japan’s health ministry has endorsed the first stem-cell therapy derived from induced pluripotent stem cells (iPSCs) for ...
On March 12, Unixell Biotech achieved a significant milestone as UX-GIP001, its iPSC-derived allogeneic cell therapy targeting focal epilepsy, secured Investigational New Drug (IND) clearance from the ...
Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...
US FDA clears Unixell Biotech’s IND for allogeneic iPSC-derived cell therapy, UX-GIP001 for focal epilepsy: Shanghai Monday, March 16, 2026, 17:00 Hrs [IST] Shanghai UniXell Bio ...
GERMANTOWN, MD / ACCESS Newswire / March 16, 2026 / uBriGene Biosciences (uBriGene), a global CDMO leader, is excited to announce that its strategic partner, Grit Biotechnologies, has received FDA ...
India, March 18 -- Stem cell therapies using induced pluripotent stem cells have received conditional approval in Japan for treating Parkinson's disease and severe heart failure, advancing ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果